메뉴 건너뛰기




Volumn 23, Issue 2, 2015, Pages 99-104

Methicillin-resistant Staphylococcus aureus infections: Role of daptomycin/ β-lactams combination;Infezioni da Staphylococcus aureus meticillino-resistente: Ruolo dell’associazione daptomicina/β-lattamici

Author keywords

Combination therapy; Daptomycin; MRSA

Indexed keywords

BETA LACTAM; CEFTAROLINE; CEFTOBIPROLE; CLOXACILLIN; DALBAVANCIN; DAPTOMYCIN; GLYCOPEPTIDE; LINEZOLID; NAFCILLIN; ORITAVANCIN; OXACILLIN; TELAVANCIN; TIGECYCLINE; VANCOMYCIN; ANTIINFECTIVE AGENT;

EID: 84936929989     PISSN: 11249390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review
Times cited : (20)

References (48)
  • 2
    • 57349200478 scopus 로고    scopus 로고
    • Decrease of methicillin resistant Staphylococcus aureus prevalence after introduction of a surgical antibiotic prophylaxis protocol in an Italian hospital
    • Nicastri E., Leone S., Petrosillo N., et al. Decrease of methicillin resistant Staphylococcus aureus prevalence after introduction of a surgical antibiotic prophylaxis protocol in an Italian hospital. New Microbiol. 31, 519- 525, 2008.
    • (2008) New Microbiol , vol.31 , pp. 519-525
    • Nicastri, E.1    Leone, S.2    Petrosillo, N.3
  • 3
    • 76749129468 scopus 로고    scopus 로고
    • A European survey of antibiotic management of methicillin- resistant Staphylococcus aureus infection: Current clinical opinion and practice
    • Dryden M., Andrasevic A.T., Bassetti M., et al. A European survey of antibiotic management of methicillin- resistant Staphylococcus aureus infection: current clinical opinion and practice. Clin. Microbiol. Infect. 16 (Suppl 1), 3-30, 2010.
    • (2010) Clin. Microbiol. Infect , vol.16 , pp. 3-30
    • Dryden, M.1    Andrasevic, A.T.2    Bassetti, M.3
  • 5
    • 84866952997 scopus 로고    scopus 로고
    • Considerations of antibiotic therapy duration in community- and hospital- acquired bacterial infections
    • Esposito S., Esposito I., Leone S. Considerations of antibiotic therapy duration in community- and hospital- acquired bacterial infections. J. Antimicrob. Chemother. 67, 2570-2575, 2012.
    • (2012) J. Antimicrob. Chemother , vol.67 , pp. 2570-2575
    • Esposito, S.1    Esposito, I.2    Leone, S.3
  • 6
    • 84883448778 scopus 로고    scopus 로고
    • Antimicrobial therapy duration: A major matter in the management of severe infections
    • Leone S., Rossi M., Bisi L., Gori A., Esposito S. Antimicrobial therapy duration: a major matter in the management of severe infections. Int. J. Antimicrob. Agents. 42, 287-288, 2013.
    • (2013) Int. J. Antimicrob. Agents , vol.42 , pp. 287-288
    • Leone, S.1    Rossi, M.2    Bisi, L.3    Gori, A.4    Esposito, S.5
  • 7
    • 0037371388 scopus 로고    scopus 로고
    • Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection
    • Engemann J.J., Carmeli Y., Cosgrove S.E., et al. Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. Clin. Infect. Dis. 36, 592-598, 2003.
    • (2003) Clin. Infect. Dis , vol.36 , pp. 592-598
    • Engemann, J.J.1    Carmeli, Y.2    Cosgrove, S.E.3
  • 8
    • 4143111197 scopus 로고    scopus 로고
    • Clinical and economic analysis of methicillin-susceptible and -resistant Staphylococcus aureus infections
    • Kopp B.J., Nix D.E., Armstrong E.P. Clinical and economic analysis of methicillin-susceptible and -resistant Staphylococcus aureus infections. Ann. Pharmacother. 38, 1377-1382, 2004.
    • (2004) Ann. Pharmacother , vol.38 , pp. 1377-1382
    • Kopp, B.J.1    Nix, D.E.2    Armstrong, E.P.3
  • 9
    • 15944419940 scopus 로고    scopus 로고
    • The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: Mortality, length of stay, and hospital charges
    • Cosgrove S.E., Qi Y., Kaye K.S., Harbarth S., Karchmer A.W., Carmeli Y. The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges. Infect. Control. Hosp. Epidemiol. 26, 166-174, 2005.
    • (2005) Infect. Control. Hosp. Epidemiol , vol.26 , pp. 166-174
    • Cosgrove, S.E.1    Qi, Y.2    Kaye, K.S.3    Harbarth, S.4    Karchmer, A.W.5    Carmeli, Y.6
  • 10
    • 34147162424 scopus 로고    scopus 로고
    • Antimicrobial treatment for Intensive Care Unit (ICU) infections including the role of the infectious disease specialist
    • Esposito S., Leone S. Antimicrobial treatment for Intensive Care Unit (ICU) infections including the role of the infectious disease specialist. Int. J. Antimicrob. Agents. 29, 494-500, 2007.
    • (2007) Int. J. Antimicrob. Agents , vol.29 , pp. 494-500
    • Esposito, S.1    Leone, S.2
  • 12
    • 0037235347 scopus 로고    scopus 로고
    • Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: A meta-analysis
    • Cosgrove S.E., Sakoulas G., Perencevich E.N., Schwaber M.J., Karchmer A.W., Carmeli Y. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin. Infect. Dis. 36, 53-59, 2003.
    • (2003) Clin. Infect. Dis , vol.36 , pp. 53-59
    • Cosgrove, S.E.1    Sakoulas, G.2    Perencevich, E.N.3    Schwaber, M.J.4    Karchmer, A.W.5    Carmeli, Y.6
  • 13
    • 84867744315 scopus 로고    scopus 로고
    • Epidemiology, characteristics, and outcome of infective endocarditis in Italy: The Italian Study on Endocarditis
    • Leone S., Ravasio V., Durante-Mangoni E., et al. Epidemiology, characteristics, and outcome of infective endocarditis in Italy: the Italian Study on Endocarditis. Infection. 40, 527-535, 2012.
    • (2012) Infection , vol.40 , pp. 527-535
    • Leone, S.1    Ravasio, V.2    Durante-Mangoni, E.3
  • 14
    • 69249130551 scopus 로고    scopus 로고
    • Feedback dose alteration significantly affects probability of pathogen eradication in nosocomial pneumonia
    • Scaglione F., Esposito S., Leone S., et al. Feedback dose alteration significantly affects probability of pathogen eradication in nosocomial pneumonia. Eur. Respir. J. 34, 394-400, 2009.
    • (2009) Eur. Respir. J , vol.34 , pp. 394-400
    • Scaglione, F.1    Esposito, S.2    Leone, S.3
  • 15
    • 80051551629 scopus 로고    scopus 로고
    • Intra-abdominal infections: Model of antibiotic stewardship in an era with limited antimicrobial options
    • Leone S., Stefani S., Venditti M., et al. Intra-abdominal infections: model of antibiotic stewardship in an era with limited antimicrobial options. Int. J. Antimicrob. Agents 38, 271-272, 2011.
    • (2011) Int. J. Antimicrob. Agents , vol.38 , pp. 271-272
    • Leone, S.1    Stefani, S.2    Venditti, M.3
  • 16
    • 70350503362 scopus 로고    scopus 로고
    • Analysis of current guidelines for intra-abdominal infections
    • Esposito S., Leone S., Carosi G. Analysis of current guidelines for intra-abdominal infections. J. Chemother. 21 (Suppl. 1), 30-35, 2009.
    • (2009) J. Chemother , vol.21 , pp. 30-35
    • Esposito, S.1    Leone, S.2    Carosi, G.3
  • 17
    • 84857759783 scopus 로고    scopus 로고
    • Diagnosis and management of skin and soft-tissue infections (SSTI): A literature review and consensus statement on behalf of the Italian Society of Infectious Diseases and International Society of Chemotherapy
    • Esposito S., Bassetti M., Borrè S., et al. Diagnosis and management of skin and soft-tissue infections (SSTI): a literature review and consensus statement on behalf of the Italian Society of Infectious Diseases and International Society of Chemotherapy. J. Chemother. 23, 251-262, 2011.
    • (2011) J. Chemother , vol.23 , pp. 251-262
    • Esposito, S.1    Bassetti, M.2    Borrè, S.3
  • 18
    • 48149097056 scopus 로고    scopus 로고
    • Foot infections in diabetes (DFIs) in the out-patient setting: An Italian multicentre observational survey
    • Esposito S., Leone S., Noviello S., et al. Foot infections in diabetes (DFIs) in the out-patient setting: an Italian multicentre observational survey. Diabet. Med. 25, 979-984, 2008.
    • (2008) Diabet. Med , vol.25 , pp. 979-984
    • Esposito, S.1    Leone, S.2    Noviello, S.3
  • 20
    • 77249088608 scopus 로고    scopus 로고
    • Italian guidelines for the diagnosis and infectious disease management of osteomyelitis and prosthetic joint infections in adults
    • Esposito S., Leone S., Bassetti M., et al. Italian guidelines for the diagnosis and infectious disease management of osteomyelitis and prosthetic joint infections in adults. Infection 37, 478-496, 2009.
    • (2009) Infection , vol.37 , pp. 478-496
    • Esposito, S.1    Leone, S.2    Bassetti, M.3
  • 21
    • 78149279830 scopus 로고    scopus 로고
    • Consensus document on controversial issues in the diagnosis and treatment of prosthetic joint infections
    • Leone S., Borrè S., Monforte A., et al. Consensus document on controversial issues in the diagnosis and treatment of prosthetic joint infections. Int. J. Infect. Dis. 14 (Suppl. 4), 67-77, 2010.
    • (2010) Int. J. Infect. Dis , vol.14 , pp. 67-77
    • Leone, S.1    Borrè, S.2    Monforte, A.3
  • 22
    • 50549104733 scopus 로고    scopus 로고
    • Prosthetic joint infections: Microbiology, diagnosis, management and prevention
    • Esposito S., Leone S. Prosthetic joint infections: microbiology, diagnosis, management and prevention. Int. J. Antimicrob. Agents. 32, 287-293, 2008.
    • (2008) Int. J. Antimicrob. Agents , vol.32 , pp. 287-293
    • Esposito, S.1    Leone, S.2
  • 23
    • 84855484682 scopus 로고    scopus 로고
    • New insights into methicillin-resistant Staphylococcus aureus (MRSA) pathogenesis, treatment and resistance. Int. J. Antimicrob
    • Gould I.M., David M.Z., Esposito S., et al. New insights into methicillin-resistant Staphylococcus aureus (MRSA) pathogenesis, treatment and resistance. Int. J. Antimicrob. Agents 39, 96-104, 2012.
    • (2012) Agents , vol.39 , pp. 96-104
    • Gould, I.M.1    David, M.Z.2    Esposito, S.3
  • 24
    • 2942558870 scopus 로고    scopus 로고
    • Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia
    • Sakoulas G., Moise-Broder P.A., Schentag J., et al. Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia. J. Clin. Microbiol. 42, 2398-2402, 2004.
    • (2004) J. Clin. Microbiol , vol.42 , pp. 2398-2402
    • Sakoulas, G.1    Moise-Broder, P.A.2    Schentag, J.3
  • 25
    • 33750285524 scopus 로고    scopus 로고
    • High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: Efficacy and toxicity
    • Hidayat L.K., Hsu D.I., Quist R., Shriner K.A., Wong-Beringer A. High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity. Arch. Intern. Med. 166, 2138-2144, 2006.
    • (2006) Arch. Intern. Med , vol.166 , pp. 2138-2144
    • Hidayat, L.K.1    Hsu, D.I.2    Quist, R.3    Shriner, K.A.4    Wong-Beringer, A.5
  • 26
    • 39449112495 scopus 로고    scopus 로고
    • Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia
    • Soriano A., Marco F., Martínez J.A., et al. Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia. Clin. Infect. Dis. 46, 193-200, 2008.
    • (2008) Clin. Infect. Dis , vol.46 , pp. 193-200
    • Soriano, A.1    Marco, F.2    Martínez, J.A.3
  • 27
    • 50949085411 scopus 로고    scopus 로고
    • Relationship between vancomycin MIC and failure among patients with methicillin-resistant Staphylococcus aureus bacteremia treated with vancomycin
    • Lodise T.P., Graves J., Evans A., et al. Relationship between vancomycin MIC and failure among patients with methicillin-resistant Staphylococcus aureus bacteremia treated with vancomycin. Antimicrob. Agents. Chemother. 52, 3315-3320, 2008.
    • (2008) Antimicrob. Agents. Chemother , vol.52 , pp. 3315-3320
    • Lodise, T.P.1    Graves, J.2    Evans, A.3
  • 28
    • 62449183879 scopus 로고    scopus 로고
    • Therapeutic monitoring of vancomycin in adult patients: A consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists
    • Rybak M., Lomaestro B., Rotschafer J.C., et al. Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Am. J. Health. Syst. Pharm. 66, 82-98, 2009.
    • (2009) Am. J. Health. Syst. Pharm , vol.66 , pp. 82-98
    • Rybak, M.1    Lomaestro, B.2    Rotschafer, J.C.3
  • 29
    • 84926488151 scopus 로고    scopus 로고
    • Managing skin and soft-tissue infection and nosocomial pneumonia caused by MRSA: A 2014 follow-up survey
    • Dryden M., Andrasevic A.T., Bassetti M., et al. Managing skin and soft-tissue infection and nosocomial pneumonia caused by MRSA: a 2014 follow-up survey. Int. J. Antimicrob. Agents. 45 (Suppl 1), 1-14, 2015.
    • (2015) Int. J. Antimicrob. Agents , vol.45 , pp. 1-14
    • Dryden, M.1    Andrasevic, A.T.2    Bassetti, M.3
  • 30
    • 57049125761 scopus 로고    scopus 로고
    • In vitro activity of tigecycline: MICs, MBCs, timekill curves and post-antibiotic effect
    • Noviello S., Ianniello F., Leone S., Fiore M., Esposito S. In vitro activity of tigecycline: MICs, MBCs, timekill curves and post-antibiotic effect. J. Chemother. 20, 577-580, 2008.
    • (2008) J. Chemother , vol.20 , pp. 577-580
    • Noviello, S.1    Ianniello, F.2    Leone, S.3    Fiore, M.4    Esposito, S.5
  • 31
    • 70249087298 scopus 로고    scopus 로고
    • Microbiology of drugs for treating multiply drug-resistant Gram-positive bacteria
    • Eliopoulos G.M. Microbiology of drugs for treating multiply drug-resistant Gram-positive bacteria. J. Infect. 59 (Suppl. 1), 17-24, 2009.
    • (2009) J. Infect , vol.59 , pp. 17-24
    • Eliopoulos, G.M.1
  • 32
    • 7044263236 scopus 로고    scopus 로고
    • Outpatient parenteral antibiotic therapy (OPAT) in different countries: A comparison
    • Esposito S., Noviello S., Leone S., et al. Outpatient parenteral antibiotic therapy (OPAT) in different countries: a comparison. Int. J. Antimicrob. Agents. 24, 473- 478, 2004.
    • (2004) Int. J. Antimicrob. Agents , vol.24 , pp. 473-478
    • Esposito, S.1    Noviello, S.2    Leone, S.3
  • 33
    • 67249140312 scopus 로고    scopus 로고
    • Outpatient parenteral antibiotic therapy in the elderly: An Italian observational multicenter study
    • Esposito S., Leone S., Noviello S., et al. Outpatient parenteral antibiotic therapy in the elderly: an Italian observational multicenter study. J. Chemother. 21, 193- 198, 2009.
    • (2009) J. Chemother , vol.21 , pp. 193-198
    • Esposito, S.1    Leone, S.2    Noviello, S.3
  • 34
    • 34547795298 scopus 로고    scopus 로고
    • Outpatient parenteral antibiotic therapy for bone and joint infections: An Italian multicenter study
    • Esposito S., Leone S., Noviello S., et al. Outpatient parenteral antibiotic therapy for bone and joint infections: an Italian multicenter study. J. Chemother. 19, 417- 422, 2007.
    • (2007) J. Chemother , vol.19 , pp. 417-422
    • Esposito, S.1    Leone, S.2    Noviello, S.3
  • 35
    • 70349173209 scopus 로고    scopus 로고
    • Susceptibility relationship between vancomycin and daptomycin in Staphylococcus aureus: Facts and assumptions
    • Moise P.A., North D., Steenbergen J.N., Sakoulas G. Susceptibility relationship between vancomycin and daptomycin in Staphylococcus aureus: facts and assumptions. Lancet Infect. Dis. 9, 617-624, 2009.
    • (2009) Lancet Infect. Dis , vol.9 , pp. 617-624
    • Moise, P.A.1    North, D.2    Steenbergen, J.N.3    Sakoulas, G.4
  • 36
    • 84884949156 scopus 로고    scopus 로고
    • A current perspective on daptomycin for the clinical microbiologist
    • Humphries R.M., Pollett S., Sakoulas G. A current perspective on daptomycin for the clinical microbiologist. Clin. Microbiol. Rev. 26, 759-780, 2013.
    • (2013) Clin. Microbiol. Rev , vol.26 , pp. 759-780
    • Humphries, R.M.1    Pollett, S.2    Sakoulas, G.3
  • 37
    • 84883451020 scopus 로고    scopus 로고
    • Daptomycin: The role of high-dose and combination therapy for Gram-positive infections
    • Gould I.M., Miró J.M., Rybak M.J. Daptomycin: the role of high-dose and combination therapy for Gram-positive infections. Int. J. Antimicrob. Agents 42, 202-210, 2013.
    • (2013) Int. J. Antimicrob. Agents , vol.42 , pp. 202-210
    • Gould, I.M.1    Miró, J.M.2    Rybak, M.J.3
  • 38
    • 3342957138 scopus 로고    scopus 로고
    • Synergy of daptomycin with oxacillin and other beta-lactams against methicillin- resistant Staphylococcus aureus
    • Rand K.H., Houck H.J. Synergy of daptomycin with oxacillin and other beta-lactams against methicillin- resistant Staphylococcus aureus. Antimicrob. Agents. Chemother. 48, 2871-2875, 2004.
    • (2004) Antimicrob. Agents. Chemother , vol.48 , pp. 2871-2875
    • Rand, K.H.1    Houck, H.J.2
  • 39
    • 77955374467 scopus 로고    scopus 로고
    • Daptomycin- oxacillin combinations in treatment of experimental endocarditis caused by daptomycin-nonsusceptible strains of methicillin-resistant Staphylococcus aureus with evolving oxacillin susceptibility (the "seesaw effect")
    • Yang S.J., Xiong Y.Q., Boyle-Vavra S., et al. Daptomycin- oxacillin combinations in treatment of experimental endocarditis caused by daptomycin-nonsusceptible strains of methicillin-resistant Staphylococcus aureus with evolving oxacillin susceptibility (the "seesaw effect"). Antimicrob. Agents Chemother. 54, 3161- 3169, 2010.
    • (2010) Antimicrob. Agents Chemother , vol.54 , pp. 3161-3169
    • Yang, S.J.1    Xiong, Y.Q.2    Boyle-Vavra, S.3
  • 40
    • 79959722946 scopus 로고    scopus 로고
    • Use of antistaphylococcal beta-lactams to increase daptomycin activity in eradicating persistent bacteremia due to methicillin- resistant Staphylococcus aureus: Role of enhanced daptomycin binding
    • Dhand A., Bayer A.S., Pogliano J., et al. Use of antistaphylococcal beta-lactams to increase daptomycin activity in eradicating persistent bacteremia due to methicillin- resistant Staphylococcus aureus: role of enhanced daptomycin binding. Clin. Infect. Dis. 53, 158-163, 2011.
    • (2011) Clin. Infect. Dis , vol.53 , pp. 158-163
    • Dhand, A.1    Bayer, A.S.2    Pogliano, J.3
  • 41
    • 84862532741 scopus 로고    scopus 로고
    • Efficacy of daptomycin-cloxacillin combination in experimental foreign-body infection due to methicillin-resistant Staphylococcus aureus
    • Garrigós C., Murillo O., Lora-Tamayo J., et al. Efficacy of daptomycin-cloxacillin combination in experimental foreign-body infection due to methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 56, 3806-3811, 2012.
    • (2012) Antimicrob. Agents Chemother , vol.56 , pp. 3806-3811
    • Garrigós, C.1    Murillo, O.2    Lora-Tamayo, J.3
  • 42
    • 84869215998 scopus 로고    scopus 로고
    • [-Lactams increase the antibacterial activity of daptomycin against clinical methicillin-resistant Staphylococcus aureus strains and prevent selection of daptomycin-resistant derivatives
    • Mehta S., Singh C., Plata K.B., et al. [-Lactams increase the antibacterial activity of daptomycin against clinical methicillin-resistant Staphylococcus aureus strains and prevent selection of daptomycin-resistant derivatives. Antimicrob. Agents. Chemother. 56, 6192-6200, 2012.
    • (2012) Antimicrob. Agents. Chemother , vol.56 , pp. 6192-6200
    • Mehta, S.1    Singh, C.2    Plata, K.B.3
  • 43
    • 84874090811 scopus 로고    scopus 로고
    • Multicenter evaluation of the clinical outcomes of daptomycin with and without concomitant d-lactams in patients with Staphylococcus aureus bacteremia and mild to moderate renal impairment
    • Moise P.A., Amodio-Groton M., Rashid M., et al. Multicenter evaluation of the clinical outcomes of daptomycin with and without concomitant d-lactams in patients with Staphylococcus aureus bacteremia and mild to moderate renal impairment. Antimicrob. Agents Chemother. 57, 1192-1200, 2013.
    • (2013) Antimicrob. Agents Chemother , vol.57 , pp. 1192-1200
    • Moise, P.A.1    Amodio-Groton, M.2    Rashid, M.3
  • 44
    • 84866315707 scopus 로고    scopus 로고
    • Addition of ceftaroline to daptomycin after emergence of daptomycin- nonsusceptible Staphylococcus aureus during therapy improves antibacterial activity
    • Rose W.E., Schulz L.T., Andes D., et al. Addition of ceftaroline to daptomycin after emergence of daptomycin- nonsusceptible Staphylococcus aureus during therapy improves antibacterial activity. Antimicrob. Agents Chemother. 56, 5296-5302, 2012.
    • (2012) Antimicrob. Agents Chemother , vol.56 , pp. 5296-5302
    • Rose, W.E.1    Schulz, L.T.2    Andes, D.3
  • 45
    • 84872041928 scopus 로고    scopus 로고
    • Ceftaroline increases membrane binding and enhances the activity of daptomycin against daptomycin-nonsusceptible vancomycin-intermediate Staphylococcus aureus in a pharmacokinetic/ pharmacodynamic model
    • Werth B.J., Sakoulas G., Rose W.E., Pogliano J., Tewhey R., Rybak M.J. Ceftaroline increases membrane binding and enhances the activity of daptomycin against daptomycin-nonsusceptible vancomycin-intermediate Staphylococcus aureus in a pharmacokinetic/ pharmacodynamic model. Antimicrob. Agents Chemother. 57, 66-73, 2013.
    • (2013) Antimicrob. Agents Chemother , vol.57 , pp. 66-73
    • Werth, B.J.1    Sakoulas, G.2    Rose, W.E.3    Pogliano, J.4    Tewhey, R.5    Rybak, M.J.6
  • 46
    • 84901251282 scopus 로고    scopus 로고
    • Evaluation of ceftaroline, vancomycin, daptomycin, or ceftaroline plus daptomycin against daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus in an in vitro pharmacokinetic/pharmacodynamic model of simulated endocardial vegetations
    • Werth B.J., Barber K.E., Ireland C.E., Rybak M.J. Evaluation of ceftaroline, vancomycin, daptomycin, or ceftaroline plus daptomycin against daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus in an in vitro pharmacokinetic/pharmacodynamic model of simulated endocardial vegetations. Antimicrob. Agents Chemother. 58, 3177-3181, 2014.
    • (2014) Antimicrob. Agents Chemother , vol.58 , pp. 3177-3181
    • Werth, B.J.1    Barber, K.E.2    Ireland, C.E.3    Rybak, M.J.4
  • 47
    • 84922440582 scopus 로고    scopus 로고
    • The combination of ceftaroline plus daptomycin allows for therapeutic de-escalation and daptomycin sparing against MRSA
    • Barber K.E., Werth B.J., Rybak M.J. The combination of ceftaroline plus daptomycin allows for therapeutic de-escalation and daptomycin sparing against MRSA. J. Antimicrob. Chemother. 70, 505-509, 2015.
    • (2015) J. Antimicrob. Chemother , vol.70 , pp. 505-509
    • Barber, K.E.1    Werth, B.J.2    Rybak, M.J.3
  • 48
    • 84908272497 scopus 로고    scopus 로고
    • Potent synergy of ceftobiprole plus daptomycin against multiple strains of Staphylococcus aureus with various resistance phenotypes
    • Barber K.E., Werth B.J., Ireland C.E., et al. Potent synergy of ceftobiprole plus daptomycin against multiple strains of Staphylococcus aureus with various resistance phenotypes. J. Antimicrob. Chemother. 69, 3006- 3010, 2014.
    • (2014) J. Antimicrob. Chemother , vol.69 , pp. 3006-3010
    • Barber, K.E.1    Werth, B.J.2    Ireland, C.E.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.